FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to a cell line of osteogenic human sarcoma 793 OsSar RVV. Line is used for preparing biomedical cell products and testing anti-tumor preparations, expresses cancer-testicular antigens NY-ESO-1, MAGE, BAGE, GAGE, PASD1 and SSX1, is a producer of follistatin, G-CSF, hepatocyte growth factor, leptin, osteopontin and is stored in Specialized collection of vertebrate cell cultures of Russian collection of cell cultures under registration number RKKK(P) 789D.
EFFECT: invention widens the range of equipment.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HUMAN SYNOVIAL SARCOMA CELL LINE 716 SS MNV | 2020 |
|
RU2740800C1 |
| HUMAN BLADDER CANCER CELL LINE 190 BICAN KAG | 2021 |
|
RU2779948C1 |
| HUMAN EMBRYONIC RHABDOMYOSARCOMA CELL LINE 862 RMSAR KDD | 2020 |
|
RU2737248C1 |
| HUMAN ALVEOLAR SARCOMA CELL LINE 9927 AIS SIO | 2022 |
|
RU2796356C1 |
| APPLICATION OF CELL LINE OF 369 ADMEL HUMAN SKIN MELANOMA | 2017 |
|
RU2642265C1 |
| HUMAN BLADDER CANCER CELL LINE 587 BLCAN TVV | 2020 |
|
RU2742244C1 |
| HUMAN BLADDER CANCER CELL LINE 198 BLCAN RLA | 2019 |
|
RU2733230C1 |
| APPLICATION OF HUMAN SKIN MELANOMA CELL LINE 388mel | 2018 |
|
RU2675541C1 |
| APPLICATION OF CELL LINE OF RC291C CLEAR CELL ADENOCARCINOMA | 2018 |
|
RU2673729C1 |
| HUMAN BLADDER CANCER CELL LINE 398 BLCAN KAE | 2020 |
|
RU2742245C1 |
